CLOs on the Move

Companion Medical

www.companionmedical.com

 
Companion Medical is a leader in the development of advanced technology to improve diabetes care. Companion`s InPen system is available in the U.S. and is the only FDA-cleared, smart insulin pen paired with an integrated diabetes management app.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Wolff Medical Supply

Wolff Medical Supply is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avalign Technologies

Avalign Technologies is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Swiss-American Products dba as elta Skin and Wounc Care

Swiss-American Products dba as elta Skin & Wounc Care is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NovaSignal

NovaSignal Corp. is a medical technology company whose mission is to save lives by unlocking the hidden power of blood flow data. The company`s FDA-cleared NovaGuide™ Intelligent Ultrasound combines non-invasive ultrasound, robotics, and artificial intelligence to assess real-time cerebral blood flow. Through the use of cloud computing and data analytics services, NovaSignal supports physicians in their clinical decision making, leading to better patient outcomes.

Contego Medical

Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.